5-Bromo-4-methylpyrimidine

Catalog No.: 
ACJRFW302
CAS No.: 
1439-09-4
Molecular Formula: 
C5H5BrN2
Molecular Weight: 
173.01
5-Bromo-4-methylpyrimidine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g98%$76.00In stockInquiry
10g98%$144.00In stockInquiry
25g98%$357.00In stockInquiry
100g98%$1199.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-Bromo-4-methylpyrimidine
IUPAC Name5-bromo-4-methylpyrimidine
MDL No.MFCD10000597
Molecular FormulaC5H5BrN2
Molecular Weight173.01
SMILESBrC1=CN=CN=C1C
InChI KeyALRPHTZYJPXPGN-UHFFFAOYSA-N
Synonym5-Bromo-4-methylpyrimidine | 1439-09-4 | 5-Bromo-4-methyl-pyrimidine | MFCD10000597 | Pyrimidine, 5-bromo-4-methyl- (7CI,8CI,9CI) | PYRIMIDINE, 5-BROMO-4-METHYL- | SCHEMBL360568 | 5-bromanyl-4-methyl-pyrimidine | DTXSID30499201 | ALRPHTZYJPXPGN-UHFFFAOYSA-N | BCP19479 | AKOS00
CAS No.1439-09-4
PubChem CID12461863

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H332-H335
Precautionary Statement(s)
P261-P280-P305+P351+P338

Synthetic Route by SureRoute

1. ACJRFW302 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACDHFS615 route compound structure diagram
    ACDHFS61517321-93-6In Stock
  2. Then
  3. ACJRFW302 route product structure diagram
    ACJRFW3021439-09-4In Stock
Inquiry

2. ACJRFW302 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACSAIW213 route compound structure diagram
    ACSAIW2134595-59-9In Stock
  2. Then
  3. ACJRFW302 route product structure diagram
    ACJRFW3021439-09-4In Stock
Inquiry

3. ACJRFW302 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACPTMJ546 route compound structure diagram
    ACPTMJ546633328-95-7In Stock
  2. Then
  3. ACJRFW302 route product structure diagram
    ACJRFW3021439-09-4In Stock
Inquiry

Comments (0)